The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …

Background The Xpert MTB/RIF assay has garnered significant interest as a sensitive and
rapid diagnostic tool to improve detection of sensitive and drug resistant tuberculosis. However…

Background Most SARS-CoV-2 infected patients develop IgG antibodies within 2–3 weeks
after symptom onset. Antibody levels have been shown to gradually decrease in the first …

The human- and animal-adapted lineages of the Mycobacterium tuberculosis complex (MTBC)
are thought to have expanded from a common progenitor in Africa. However, the …

We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …

The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …

Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …

To the Editor—To and colleagues reported the first documented case of an asymptomatic
reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after 4.5 …

The emergence of SARS-CoV-2 variants of concern (VoCs) has exacerbated the COVID-19
pandemic. End of November 2021, a new SARS-CoV-2 variant namely the omicron (B.1.1.…

Objectives The aim was to determine the antibody response against SARS-CoV-2 spike
protein and nucleoprotein using four automated immunoassays and three ELISAs for the …